Anna Orlova

Uppsala University

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (11)

Collaborators (6)

Sophia Hober

KTH Royal Institute of Technology

Fredrik Frejd

Uppsala University

Vladimir Tolmachev

Uppsala University

Ulrika Rosenström

Uppsala Universitet Farmaceutiska fakulteten

Anzhelika Vorobyeva

Uppsala University

Sara Sophie Rinne

Weill Cornell Medicine

UNITED STATES

Anna Orlova

Research Interests

Explore related searches

Contact this professor

Articles (11)

Collaborators (6)

Sophia Hober

Fredrik Frejd

Vladimir Tolmachev

Ulrika Rosenström

Anzhelika Vorobyeva

Sara Sophie Rinne

How do I reach out?

Meet Kite AI

Anna Orlova

Research Interests

Explore related searches

Contact this professor

Articles (11)

Two Novel [<sup>68</sup>Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar<sup>11</sup>]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer

Phase I Trial of [<sup>99m</sup>Tc]Tc-maSSS-PEG<sub>2</sub>-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model

Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics

Synthesis, <sup>123</sup>I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity

Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy

Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer

Collaborators (6)

Sophia Hober

Fredrik Frejd

Vladimir Tolmachev

Ulrika Rosenström

Anzhelika Vorobyeva

Sara Sophie Rinne

How do I reach out?

Meet Kite AI